11th annual ADMET conference and exhibition

The SMi Group is proud to announce the return of the 11th annual ADMET conference taking place in London on the 13th – 14th June.

This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.

ADMET 2016 will provide a series of practical case studies, interactive roundtables and panel discussions facilitated by leading industry experts that will provide executives with useful tools and best practices to:

Discover application of PBPK to drug development in rare diseases
Review the role of drug transporters in drug delivery to CNS diseases
Learn about better models for understanding, predicting and avoiding drug induced liver injury
Discuss in silico approaches to evidence-based mechanistic modelling
Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules

2016 Speaker Line up:
CHAIRMAN:
Thierry Lave, Head DMPK Discovery and Development Project Leaders (CNS/CVM), Roche
KEYNOTE SPEAKERS:
Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
Kunal Taskar, Senior Investigator, DMPK, GSK
Karelle Menochet, Principal Scientist DMPK, UCB Pharma
Laurent Salphati, Senior Scientist, Genentech
Carl Petersson, DMPK NCE Senior Designer, Merck Serono
Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck